KalVista Pharmaceuticals (KALV) Return on Assets (QoQ) (2015 - 2025)

KalVista Pharmaceuticals (KALV) Return on Assets (QoQ) (2015 - 2025) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 KalVista Pharmaceuticals 1.36 Bn 1.36 Bn 49.41 Mn

Historic Data

Download Data
DateValue
Jul 31, 2025 0.00
Oct 31, 2024 0.00
Jul 31, 2024 0.00
Apr 30, 2024 1.00
Jan 31, 2024 0.00
Oct 31, 2023 0.00
Jul 31, 2023 0.00
Apr 30, 2023 0.00
Jan 31, 2023 0.00
Oct 31, 2022 0.00
Jul 31, 2022 0.00
Apr 30, 2022 0.00
Jan 31, 2022 0.00
Oct 31, 2021 0.00
Jul 31, 2021 0.00
Apr 30, 2021 0.00
Jan 31, 2021 0.00
Oct 31, 2020 0.00
Jul 31, 2020 0.00
Apr 30, 2020 0.00